血管节痛:病理生理学,诊断和新兴的治疗方法
Kristoffer Ken Ralota1, Jamie Layland2
1Department of Cardiology, Peninsula Health, Frankston 3199, Victoria, Australia.
World journal of cardiology
|November 3, 2025
概括
血管性心痛 (VSA) 是一种冠状动脉的情况,导致缺血,没有阻塞. 本综述涵盖了诊断,当前的治疗方法,如管阻断剂,以及对VSA的新兴疗法.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
背景情况:
- 血管紧张性心痛 (VSA) 是心肌缺血的一个未被确诊的原因,其特征是冠状动脉,但没有显著的狭窄.
- 它是由内皮功能障碍,血管过敏反应,炎症和自主性失调引起的,可能导致严重的心脏事件.
研究的目的:
- 审查目前对血管节性心痛 (VSA) 的理解.
- 讨论基于指南的VSA的诊断和治疗策略.
- 突出针对耐火性VSA的新型和试验性治疗方法.
主要方法:
- 这篇叙事综述综合了目前关于VSA的文献.
- 它检查了既定的诊断标准和药理挑测试.
- 它分析了当前和新兴的治疗选择.
主要成果:
- VSA涉及复杂的病理生理机制,包括内皮功能障碍和光滑肌肉过度反应.
- 标准治疗包括通道阻断剂和酸盐.
- 新兴的治疗方法,如Rho-酶抑制剂和内甲素受体对抗剂,对耐火性病例显示出有前途.
结论:
- VSA需要全面的诊断方法,通常包括挑性测试.
- 目前的治疗依赖于血管扩张剂,但新药正在扩大治疗选择.
- 对VSA病理生理学和治疗的进一步研究对于改善患者的治疗结果至关重要.
相关概念视频
Angina IV: Management
230
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
230
Angina V: Nursing Management
283
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
283
Coronary Artery Disease V: Interprofessional Care
208
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
208
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Angina III: Clinical Manifestations and Assessment
196
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
196
Angina II: Classification
315
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
315


